A critical analysis of the review on antimicrobial resistance report and the infectious disease financing facility

Over the past year, two major policy initiatives have been introduced focusing on stimulating antibiotic development for human consumption. The European Investment Bank has announced the development of the Infectious Disease Financing Facility (IDFF) and the British government commissioned the Revie...

Full description

Saved in:

Bibliographic Details
Published in:	Globalization and health Vol. 12; no. 1; p. 8
Main Authors:	Brogan, David M., Mossialos, Elias
Format:	Journal Article
Language:	English
Published:	London BioMed Central 22.03.2016 BioMed Central Ltd Springer Nature B.V
Subjects:	Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - therapeutic use Antimicrobial agents Capital Financing - methods Commentary Communicable Disease Control - methods Communicable diseases Communicable Diseases - drug therapy Development Economics Drug resistance Drug resistance in microorganisms Drug Resistance, Microbial - drug effects Drug therapy Epidemiology Evaluation Forecasts and trends Health Services Research Humans Incentives Infectious diseases International Cooperation Medicine Medicine & Public Health Pharmaceutical industry Public Health Public Health - methods Public health administration Quality of Life Research R&D Research & development Social Policy International Disease Financing Facility Antibiotic development Review on Antimicrobial Resistance
ISSN:	1744-8603, 1744-8603
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!